NCT05072496View on ClinicalTrials.gov

Study on Antibody Persistence and Immune Memory of Inactivated COVID-19 Vaccine

CompletedOBSERVATIONAL
Enrollment

150

Participants

Timeline

Start Date

July 20, 2020

Primary Completion Date

August 30, 2021

Study Completion Date

September 27, 2021

Conditions
COVID-19
Trial Locations (1)

Unknown

Beijing Center for Disease Control and Prevention, Beijing

All Listed Sponsors
lead

Centers for Disease Control and Prevention, China

OTHER_GOV

NCT05072496 - Study on Antibody Persistence and Immune Memory of Inactivated COVID-19 Vaccine | Biotech Hunter | Biotech Hunter